Sentence examples for eventual recurrence from inspiring English sources

This may explain why traditional chemotherapies can initially reduce the majority of the tumor bulk but fail to eradicate it in full, allowing eventual recurrence [1], [11], [17], [18], [22].

The existence of cancer stem-like cells may explain why conventional anti-cancer therapies are able only to suppress or shrink a tumor but often cannot completely eradicate it, resulting in eventual recurrence [6], [40], [41].

Thirdly, the stem-retaining method may leave a biofilm around the stem, which might mean eventual recurrence of infection.

The primary endpoint of a correlative study (SHIP36B) is the biopsy results at 36 months following treatment to examine the relationship between results and eventual recurrence after completion of radiotherapy.

The primary endpoint and the secondary endpoints are the bPFS at 7 years and OS (or DSS) at 10 years, respectively, following initial HT with CAB to investigate the relationship between results and eventual recurrence after completion of trimodality therapy.

In the correlative study (SHIP36B), we also evaluate biopsy results at 36 months following treatment to examine the relationship between the results and the eventual recurrence after completion of radiotherapy.

Among the 14 EM patients with known eventual clinical recurrence, 13 patients had positive ctDNA levels for one or more follow-up plasma time-points and only patient EM3 had undetectable ctDNA (Fig 4A– C and Supplementary Fig S2).

A study published recently found nuclear NF- κB expression as an independent prognostic marker of eventual biochemical recurrence in a series of 42 men, all of them with positive surgical margins after radical prostatectomy.

On the other hand, it was previously reported that the correlation between biopsy results at 6-36 months after completion of radiotherapy and the eventual development of recurrence after completion of radiotherapy was highly significant retrospectively [ 7].

Using an approach combining low-coverage whole-genome sequencing of primary tumors and quantification of tumor-specific rearrangements in plasma by droplet digital PCR, we identify for the first time that ctDNA monitoring is highly accurate for postsurgical discrimination between patients with (93%) and without (100%) eventual clinically detected recurrence.

In a retrospective analysis, Scardino et al. [ 7] previously reported that by analyzing the 140 patients who had one or more needle biopsies performed 6-36 months after completion of radiotherapy, 32% patients had one or more biopsies positive for cancer, and concluded that the correlation between biopsy results and the eventual development of recurrence was highly significant.